After last year's downturn, investors are finally witnessing a solid performance by equity markets. The S&P 500 has technically been in a bull market since June 8, when it closed 20% up from its most recent low. And given that bull runs last for an average of 2.6 years (according to some research), this could only be the beginning.

There are plenty of excellent stocks to consider buying to ride this upward wave. Let's consider two solid candidates: Teladoc (NYSE: TDOC) and Tandem Diabetes Care (NASDAQ: TNDM). These stocks remain down over the trailing-12-month period, but here is why they could move in the opposite direction in the long run.

Slowing revenue growth and worsening net losses are a bad combination for any company. That's what Teladoc dealt with last year, but the company has improved, at least somewhat, on one of those fronts in 2023. Teladoc is recording much better bottom lines than in 2022, although it remains unprofitable.

Continue reading

Source Fool.com